• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

PE Firm Sycamore Partners Acquires Walgreens in $23.7B Deal

by Fred Pennic 03/06/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Walgreens, Pearl Health Partner to Expand Value-Based Care Delivery

What You Should Know: 

– Walgreens Boots Alliance (WBA) has announced a definitive agreement to be acquired by an entity affiliated with Sycamore Partners, a private equity firm specializing in retail, consumer, and distribution-related investments. 

– The total value of the transaction is estimated to be up to $23.7B.

Deal Structure and Shareholder Value

WBA shareholders will receive $11.45 per share in cash at closing, along with a non-transferable right (DAP Right) to receive up to $3.00 per share from the future monetization of WBA’s debt and equity interests in VillageMD, which includes Village Medical, Summit Health, and CityMD businesses. This brings the total potential consideration to $14.45 per share.

The deal represents a 29% premium over WBA’s closing share price on December 9, 2024, the day before initial media reports of a potential transaction, and a potential 63% premium if the DAP Rights reach their maximum value.

Strategic Rationale and Future Direction

Sycamore Partners’ acquisition aims to leverage WBA’s healthcare expertise and Sycamore’s retail and consumer services leadership. The company will continue to operate under the Walgreens and Boots brands, maintaining its headquarters in the Chicago area. The goal is to position WBA as the first choice for pharmacy, retail, and health services.

Transaction Details and Approvals

The WBA Board of Directors has unanimously approved the transaction, with Stefano Pessina and John Lederer recused. The deal is expected to close in the fourth quarter of calendar year 2025, subject to customary closing conditions, including shareholder and regulatory approvals. The transaction is not subject to a financing condition, as Sycamore has secured fully committed financing.

Upon completion, WBA’s common stock will be delisted from the Nasdaq Stock Market, and the company will become private.

“Go-Shop” Period and Shareholder Agreements

The agreement includes a 35-day “go-shop” period, allowing WBA to solicit alternative proposals. However, there is no guarantee of a superior offer.

WBA’s Executive Chairman, Stefano Pessina, and his holding company, owning approximately 17% of WBA’s shares, have entered into voting and reinvestment agreements. They will vote in favor of the transaction and reinvest their cash consideration, along with an additional investment, into the acquiring company, maintaining a significant equity stake.

VillageMD Value Maximization

A committee will be formed to maximize the value of WBA’s interests in VillageMD, considering various options, including operational enhancements and balance sheet strengthening. WBA shareholders will receive DAP Rights, with 70% of net proceeds from any VillageMD sale payable to DAP Right holders, up to $3.00 per share.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Healthcare Mergers & Acquisitions, Walgreens

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Oracle Health Launches AI Center of Excellence for Healthcare

Oracle Health Launches AI Center of Excellence for Healthcare

Particle Health Addresses Integration to Epic Data Despite Dispute

US Court Allows Particle’s Antitrust Claims Against Epic to Proceed

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Evernorth Health Services Invests $3.5B in Shields Health Solutions

Evernorth Health Services Invests $3.5B in Shields Health Solutions

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |